Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Davis

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Future Oncology (London, England)|April 17, 2024
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world studyMuhammad Furqan, Siddharth Karanth, Ravi K Goyal, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 21, 2018
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal InsulinLawrence Blonde, Denis Raccah, Elisheva Lew, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|June 7, 2019
Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical PracticeLawrence Blonde, Stephen A Brunton, Pavan Chava, et al.
Ejhaem|July 18, 2022
Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UKPeter Hillmen, Jing Xie, Alan S M Yong, et al.
Future Oncology (London, England)|April 7, 2022
Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record reviewFrancesco Passamonti, Florian H Heidel, Rohan C Parikh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2026
Real-world clinical outcomes of lenvatinib+pembrolizumab for the treatment of patients with non-microsatellite instability-high/mismatch repair proficient recurrent or advanced endometrial cancer following prior systemic therapy in the United StatesSiddhi Korgaonkar, Vimalanand S Prabhu, Rohan C Parikh, et al.
Dermatology and Therapy|April 24, 2025
Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia AreataKent A Hanson, Sergio Vañó-Galván, Andrew Messenger, et al.
Clinical and Experimental Dermatology|September 19, 2025
Findings from the Assessment of real-world Disease characteristics and outcomes in Alopecia Areata in a Global non-Interventional Observational cohort (ADAAGIO) studyKeith L Davis, Andrew Messenger, Sergio Vañó-Galván, et al.
Future Oncology (London, England)|January 27, 2025
Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinibFrancesco Passamonti, Siddhi Korgaonkar, Rohan C Parikh, et al.
Future Oncology (London, England)|February 7, 2023
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinibPaul K Paik, Ravi K Goyal, Beilei Cai, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|April 17, 2024
Effectiveness of standard treatments in non-small-cell lung cancer with METexon14 skipping mutation: a real-world studyMuhammad Furqan, Siddharth Karanth, Ravi K Goyal, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 21, 2018
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal InsulinLawrence Blonde, Denis Raccah, Elisheva Lew, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|June 7, 2019
Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical PracticeLawrence Blonde, Stephen A Brunton, Pavan Chava, et al.
Ejhaem|July 18, 2022
Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UKPeter Hillmen, Jing Xie, Alan S M Yong, et al.
Future Oncology (London, England)|April 7, 2022
Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record reviewFrancesco Passamonti, Florian H Heidel, Rohan C Parikh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 21, 2026
Real-world clinical outcomes of lenvatinib+pembrolizumab for the treatment of patients with non-microsatellite instability-high/mismatch repair proficient recurrent or advanced endometrial cancer following prior systemic therapy in the United StatesSiddhi Korgaonkar, Vimalanand S Prabhu, Rohan C Parikh, et al.
Dermatology and Therapy|April 24, 2025
Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia AreataKent A Hanson, Sergio Vañó-Galván, Andrew Messenger, et al.
Clinical and Experimental Dermatology|September 19, 2025
Findings from the Assessment of real-world Disease characteristics and outcomes in Alopecia Areata in a Global non-Interventional Observational cohort (ADAAGIO) studyKeith L Davis, Andrew Messenger, Sergio Vañó-Galván, et al.
Future Oncology (London, England)|January 27, 2025
Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinibFrancesco Passamonti, Siddhi Korgaonkar, Rohan C Parikh, et al.
Future Oncology (London, England)|February 7, 2023
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinibPaul K Paik, Ravi K Goyal, Beilei Cai, et al.
Pageof 9